TC Biopharm (Holdings) Plc (TCBP) |
|
6.77 0.35 (5.45%)
|
11-25 12:58 |
|
Open: |
6.61 |
Pre. Close: |
6.42 |
|
High:
|
6.95 |
Low:
|
6.34 |
|
Volume:
|
18,430 |
Market Cap:
|
269(M) |
|
|
|
Technical analysis |
as of: 2022-11-25 2:00:46 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 9.28 One year: 10.84 |
| Support: |
Support1: 3.12 Support2: 0.14 |
| Resistance: |
Resistance1: 7.94 Resistance2: 9.28 |
| Pivot: |
1.89  |
| Moving Average: |
MA(5): 5.36 MA(20): 1.46
MA(100): 0.55 MA(250): 0 |
| MACD: |
MACD(12,26): 1.4 Signal(9): 0.6 |
| Stochastic oscillator: |
%K(14,3): 83.9 %D(3): 76.5 |
| RSI: |
RSI(14): 94.2 |
| 52-week: |
High: 7.94 Low: 0.14 |
| Average Vol(K): |
3-Month: 279 (K) 10-Days: 823 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ TCBP ] has closed below upper band by 7.6%. Bollinger Bands are 2477.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
6.66 - 6.7 |
6.7 - 6.73 |
|
Low:
|
5.55 - 5.59 |
5.59 - 5.62 |
|
Close:
|
6.45 - 6.52 |
6.52 - 6.58 |
|
Company Description |
|
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom. |
Headline News |
Mon, 21 Nov 2022
Healthcare Stocks Moving Monday: IMGO, CDIO, NMTC, SHC, GMVD, TCBP, IVVD, CELU - InvestorsObserver
Mon, 21 Nov 2022
TC BioPharm (Holdings) (TCBP) Stock Adds 4560.00% This Week; Should You Buy? - InvestorsObserver
Mon, 21 Nov 2022
Imago, Sotera top healthcare gainers; G Medical, TC Biopharm lead losers' pack - Seeking Alpha
Mon, 21 Nov 2022
Individual investors among TC Biopharm (Holdings) Plc's (NASDAQ:TCBP) largest shareholders, saw gain in holdings value after stock jumped 11% last week - Simply Wall St
Fri, 04 Nov 2022
European ADRs Move Higher in Friday Trading - InvestorsObserver
Thu, 03 Nov 2022
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
1 (M) |
| Shares Float |
11 (M) |
|
% Held by Insiders
|
27.8 (%) |
|
% Held by Institutions
|
12.4 (%) |
|
Shares Short
|
3 (K) |
|
Shares Short P.Month
|
4 (K) |
Stock Financials |
|
EPS
|
-0.86 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-0.86 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-368.3 |
|
Return on Assets (ttm)
|
-59.6 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
2.49 |
|
Sales Per Share
|
2.49 |
|
EBITDA (p.s.)
|
-8.16 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-6 (M) |
|
Levered Free Cash Flow
|
-4 (M) |
Stock Valuations |
|
PE Ratio
|
-7.95 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
-7.97 |
|
Price to Sales
|
2.71 |
|
Price to Cash Flow
|
-0.97 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
